| Customization: | Available |
|---|---|
| Dosage Form: | Injection |
| Dossier: | Ready |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Generic Name | Propofol Injectable Emulsion 100mg/10ml |
| Strength | 100mg/10ml |
| Packing | 5ampoules/box |
| Origin | China |
It's a white isotonic IV.
Short-acting intravenous anesthetics for the induction and maintenance of general anesthesia are also used to enhance sedation of supervised patients undergoing mechanical ventilation and to perform painless abortion under anesthesia.
The use of bispropofol usually requires the use of painkillers. Bispropofol can be used as an adjunct to spinal cord and epidural anesthesia. It is used in conjunction with commonly used preoperative medications, neuromuscular blocking drugs, inhalation anesthetics, and pain medications. As a general anesthetic to complement regional anesthesia techniques, lower doses are required.
Grown man
Anesthesia administration: It is recommended that the dose should be adjusted during administration [about 4ml(40mg) every 10 seconds for the average healthy adult] and the patient's response should be observed until clinical signs indicate that the anesthesia is working. Most adult patients younger than 55 years of age need about 2.0 to 2.5 mg/kg of bispropofol; Beyond this age, requirements generally decrease; ASA Grade III and IV patients should be given at a lower rate of about 2ml(20mg) every 10 seconds.
Maintenance of anesthesia: The concentration required to maintain anesthesia can be achieved by continuous infusion or repeated single injection of bispropofol. The rate of administration required for continuous infusion varies significantly from individual to individual, and generally rates in the range of 4 to 12 mg/kg/h maintain satisfactory anesthesia.
The dose should be given with repeated single injections, in amounts from 2.5ml(25mg) to 5.0ml(50mg) per dose, as clinically required.
ICU sedation: Continuous infusion of bispropofol is recommended when used as a sedative for patients undergoing intensive care and artificial ventilation. The infusion rate should be adjusted according to the depth of sedation required, usually 0.3 to 0.4 mg/kg/hour infusion rate range, should be able to obtain satisfactory sedation effect.
Induced abortion operation: anesthesia induction at a dose of 2.0mg/kg before surgery, if the patient has limb movement due to pain stimulation during the operation, with a dose of 0.5mg/kg added, should be able to obtain satisfactory results.
Matters needing attention:
1 Bispropofol injection should be administered by a trained anesthesiologist or intensive care unit physician. The respiratory tract should be kept unblocked during medication, with artificial ventilation and oxygen supply equipment. Bispropofol injection should not be administered by a surgeon or diagnostic surgeon. The patient must be fully recovered after general anesthesia before discharge.
2 People with epilepsy who use bispropofol may be at risk of convulsions.
3 In patients with reduced and weakened heart, respiratory, or circulatory blood flow, the use of dipropofol injection should be treated with the same caution as other anesthetics.
Intravenous anticholinergics should be considered when using bispropofol injection in combination with other drugs that may cause bradycardia.
5 Caution should be exercised in the use of dipropofol injection in patients with lipid metabolism disorders or who must use fat emulsions with caution.
6 Dual propofol injection should not be used during pregnancy, but it may be used during termination of pregnancy.
){kind=link}